MTRF1
gene geneOn this page
Also known as RF1MTTRF1MGC47721
Summary
MTRF1 (mitochondrial translation release factor 1, HGNC:7469) is a protein-coding gene on chromosome 13q14.11, encoding Peptide chain release factor 1, mitochondrial (O75570). Mitochondrial peptide chain release factor that directs the termination of translation in response to the peptide chain non-canonical stop codons AGG and AGA.
The protein encoded by this gene was determined by in silico methods to be a mitochondrial protein with similarity to the peptide chain release factors (RFs) discovered in bacteria and yeast. The peptide chain release factors direct the termination of translation in response to the peptide chain termination codons. Initially thought to have a role in the termination of mitochondria protein synthesis, a recent publication found no mitochondrial translation release functionality. Multiple alternatively spliced transcript variants have been suggested by mRNA and EST data; however, their full-length natures are not clear.
Source: NCBI Gene 9617 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 58 total
- MANE Select transcript:
NM_004294
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:7469 |
| Approved symbol | MTRF1 |
| Name | mitochondrial translation release factor 1 |
| Location | 13q14.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RF1, MTTRF1, MGC47721 |
| Ensembl gene | ENSG00000120662 |
| Ensembl biotype | protein_coding |
| OMIM | 604601 |
| Entrez | 9617 |
Gene structure
Transcript identifiers
Ensembl transcripts: 79 — 74 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000239852, ENST00000379477, ENST00000379480, ENST00000430347, ENST00000452359, ENST00000473492, ENST00000480434, ENST00000492827, ENST00000497679, ENST00000498245, ENST00000897168, ENST00000897169, ENST00000897170, ENST00000897171, ENST00000897172, ENST00000897173, ENST00000897174, ENST00000897175, ENST00000897176, ENST00000897177, ENST00000897178, ENST00000897179, ENST00000897180, ENST00000897181, ENST00000897182, ENST00000897183, ENST00000897184, ENST00000897185, ENST00000897186, ENST00000897187, ENST00000897188, ENST00000897189, ENST00000897190, ENST00000897191, ENST00000897192, ENST00000897193, ENST00000897194, ENST00000897195, ENST00000897196, ENST00000897197, ENST00000897198, ENST00000897199, ENST00000897200, ENST00000897201, ENST00000897202, ENST00000934026, ENST00000934027, ENST00000934028, ENST00000934029, ENST00000934030, ENST00000934031, ENST00000934032, ENST00000934033, ENST00000934034, ENST00000934035, ENST00000934036, ENST00000934037, ENST00000948280, ENST00000948281, ENST00000948282, ENST00000948283, ENST00000948284, ENST00000948285, ENST00000948286, ENST00000948287, ENST00000948288, ENST00000948289, ENST00000948290, ENST00000948291, ENST00000948292, ENST00000948293, ENST00000948294, ENST00000948295, ENST00000948296, ENST00000948297, ENST00000948298, ENST00000948299, ENST00000948300, ENST00000948301
RefSeq mRNA: 4 — MANE Select: NM_004294
NM_001354073, NM_001354074, NM_001354076, NM_004294
CCDS: CCDS9378
Canonical transcript exons
ENST00000379480 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000817208 | 41226432 | 41226568 |
| ENSE00000817209 | 41233890 | 41234007 |
| ENSE00001289086 | 41252645 | 41252752 |
| ENSE00001737967 | 41216369 | 41217228 |
| ENSE00003456898 | 41240261 | 41240433 |
| ENSE00003557116 | 41223256 | 41223354 |
| ENSE00003584671 | 41252949 | 41253030 |
| ENSE00003678768 | 41254529 | 41254620 |
| ENSE00003733718 | 41260493 | 41260915 |
| ENSE00003849966 | 41263485 | 41263576 |
Expression profiles
Bgee: expression breadth ubiquitous, 268 present calls, max score 90.90.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.8568 / max 94.3440, expressed in 1718 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 136960 | 7.2174 | 1690 |
| 136961 | 0.6394 | 373 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 90.90 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 87.91 | gold quality |
| rectum | UBERON:0001052 | 87.73 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.64 | gold quality |
| right adrenal gland | UBERON:0001233 | 87.18 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.09 | gold quality |
| gall bladder | UBERON:0002110 | 86.39 | gold quality |
| left adrenal gland | UBERON:0001234 | 86.11 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 86.08 | gold quality |
| granulocyte | CL:0000094 | 86.03 | gold quality |
| pancreas | UBERON:0001264 | 86.02 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.94 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 85.77 | gold quality |
| body of stomach | UBERON:0001161 | 85.65 | gold quality |
| metanephros cortex | UBERON:0010533 | 85.45 | gold quality |
| gastrocnemius | UBERON:0001388 | 85.17 | gold quality |
| lymph node | UBERON:0000029 | 85.08 | gold quality |
| adrenal gland | UBERON:0002369 | 85.07 | gold quality |
| adrenal cortex | UBERON:0001235 | 84.95 | gold quality |
| spleen | UBERON:0002106 | 84.95 | gold quality |
| right testis | UBERON:0004534 | 84.89 | gold quality |
| muscle of leg | UBERON:0001383 | 84.79 | gold quality |
| left testis | UBERON:0004533 | 84.69 | gold quality |
| monocyte | CL:0000576 | 84.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.57 | gold quality |
| small intestine | UBERON:0002108 | 84.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.33 | gold quality |
| mononuclear cell | CL:0000842 | 84.28 | gold quality |
| right lobe of liver | UBERON:0001114 | 84.14 | gold quality |
| testis | UBERON:0000473 | 84.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.58 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
48 targeting MTRF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-3120-3P | 99.54 | 70.28 | 2669 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-3911 | 99.38 | 66.95 | 1087 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
Literature-anchored findings (GeneRIF, showing 4)
- Purified mtRF1 did not induce translation termination in vitro nor did mtRF1 restore mitochondrial translation machinery in mutated S. cerevisiae in vivo. A different mtRF, mtRF1a, was found. (PMID:17803939)
- Human mtRF1 terminates COX1 translation and its ablation induces mitochondrial ribosome-associated quality control. (PMID:36302763)
- Human mitochondria require mtRF1 for translation termination at non-canonical stop codons. (PMID:36596788)
- Molecular basis of translation termination at noncanonical stop codons in human mitochondria. (PMID:37141370)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mtrf1 | ENSDARG00000033579 |
| mus_musculus | Mtrf1 | ENSMUSG00000022022 |
| rattus_norvegicus | Mtrf1 | ENSRNOG00000047106 |
| drosophila_melanogaster | mRF1 | FBGN0032486 |
Paralogs (2): MTRF1L (ENSG00000112031), MRPL58 (ENSG00000167862)
Protein
Protein identifiers
Peptide chain release factor 1, mitochondrial — O75570 (reviewed: O75570)
All UniProt accessions (5): A0A087WZ41, A0A087X1S1, O75570, Q8N6Z2, X6RFD4
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial peptide chain release factor that directs the termination of translation in response to the peptide chain non-canonical stop codons AGG and AGA. Non-canonical termination codons AGG and AGA are found at the end of MT-CO1/COX1 and MT-ND6/ND6 open reading frames, respectively. Recognizes non-canonical stop codons via a network of interactions between the codon, MTRF1 and the ribosomal RNA (rRNA): in contrast to other translation release factors, which identify the codon in the A-site via direct interactions of amino acid side chains with the bases, MTRF1 repositions the first 2 bases of the stop codon to use an intricate network of interactions that includes residues of the release factor, the rRNA of the small ribosomal subunit, as well as neighboring bases of the mRNA.
Subcellular location. Mitochondrion.
Post-translational modifications. Methylation of glutamine in the GGQ triplet by HEMK1 is conserved from bacteria to mammals.
Domain organisation. The GGQ domain interacts with the peptidyltransferase center (PTC) of the large ribosomal subunit to trigger nascent chain hydrolysis.
Similarity. Belongs to the prokaryotic/mitochondrial release factor family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75570-1 | 1 | yes |
| O75570-2 | 2 |
RefSeq proteins (4): NP_001341002, NP_001341003, NP_001341005, NP_004285* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000352 | Pep_chain_release_fac_I | Domain |
| IPR005139 | PCRF | Domain |
| IPR045853 | Pep_chain_release_fac_I_sf | Homologous_superfamily |
| IPR050057 | Prokaryotic/Mito_RF | Family |
Pfam: PF00472, PF03462
UniProt features (19 total): sequence conflict 8, sequence variant 3, splice variant 2, transit peptide 1, chain 1, mutagenesis site 1, region of interest 1, short sequence motif 1, modified residue 1
Structure
Experimental structures (PDB)
6 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 8OIR | ELECTRON MICROSCOPY | 3.1 |
| 8OIQ | ELECTRON MICROSCOPY | 3.5 |
| 8OIN | ELECTRON MICROSCOPY | 3.6 |
| 8OIP | ELECTRON MICROSCOPY | 3.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75570-F1 | 80.03 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 313
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 311–312 | impaired mitochondrial peptide chain release factor activity. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5419276 | Mitochondrial translation termination |
MSigDB gene sets: 74 (showing top):
GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATIONAL_TERMINATION, GOBP_TRANSLATION, MARTIN_NFKB_TARGETS_UP, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, chr13q14, GOCC_MITOCHONDRIAL_MATRIX, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, STEIN_ESRRA_TARGETS_UP, GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY, GOBP_MITOCHONDRIAL_GENE_EXPRESSION, GOMF_TRANSLATION_TERMINATION_FACTOR_ACTIVITY, PRC2_SUZ12_UP.V1_UP, REACTOME_MITOCHONDRIAL_TRANSLATION, DCA_UP.V1_DN
GO Biological Process (3): mitochondrial translational termination (GO:0070126), translation (GO:0006412), translational termination (GO:0006415)
GO Molecular Function (2): translation release factor activity (GO:0003747), translation release factor activity, codon specific (GO:0016149)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 2 |
| translational termination | 2 |
| mitochondrial translation | 1 |
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| translation | 1 |
| protein-containing complex disassembly | 1 |
| translation termination factor activity | 1 |
| translation release factor activity | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular organelle lumen | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1972 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MTRF1 | MRPL58 | Q14197 | 732 |
| MTRF1 | HEMK1 | Q9Y5R4 | 725 |
| MTRF1 | MTIF2 | P46199 | 724 |
| MTRF1 | MRRF | Q96E11 | 706 |
| MTRF1 | GFM2 | Q969S9 | 664 |
| MTRF1 | MTIF3 | Q9H2K0 | 630 |
| MTRF1 | MRPS11 | P82912 | 569 |
| MTRF1 | VWA8 | A3KMH1 | 564 |
| MTRF1 | WBP4 | O75554 | 540 |
| MTRF1 | HEMK2 | Q9Y5N5 | 530 |
| MTRF1 | TUFM | P49411 | 510 |
| MTRF1 | MRPS31 | Q92665 | 507 |
| MTRF1 | GFM1 | Q96RP9 | 492 |
| MTRF1 | LAMTOR5 | O43504 | 468 |
| MTRF1 | MRPL35 | Q9NZE8 | 467 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MTRF1 | KRT8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MYC | psi-mi:“MI:0914”(association) | 0.350 | |
| MTRF1 | MEIS1 | psi-mi:“MI:0914”(association) | 0.350 |
| CLPP | NDUFA4 | psi-mi:“MI:2364”(proximity) | 0.270 |
| VWA8 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (250): MTRF1 (Affinity Capture-RNA), MTRF1 (Synthetic Lethality), KRT8 (Proximity Label-MS), MTRF1 (Proximity Label-MS), MTRF1 (Proximity Label-MS), MTRF1 (Proximity Label-MS), MTRF1 (Proximity Label-MS), AARS2 (Proximity Label-MS), ABCB7 (Proximity Label-MS), ACAD9 (Proximity Label-MS), ACAT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT2 (Proximity Label-MS), AFG3L2 (Proximity Label-MS), AK4 (Proximity Label-MS)
ESM2 similar proteins: A1AX02, A2RVR7, A5CCS8, A5IED7, A6SXF4, A9IMM3, B0B9D0, B0BB09, B2ITM5, B3CQD1, B7K205, B9KIV2, F4I532, O44568, O75570, O84026, P30775, P41767, P59456, P75420, Q09691, Q110D7, Q1LTH5, Q2GDG2, Q2GE03, Q2GGM5, Q2GKS8, Q2KI15, Q3KMZ9, Q3MF91, Q3MHI7, Q3YS23, Q47WT4, Q492V8, Q4V7E5, Q5FGZ2, Q5HB80, Q5L6U9, Q5PAH2, Q68WK7
Diamond homologs: A0Q312, A0Q844, A1U367, A3DIL4, A4IWC1, A4JB50, A4XR61, A5CCS8, A5HY35, A5IED7, A5V9C3, A5VYG5, A6Q162, A6W1C2, A7FQG2, A7G9P2, A7HTY3, A7NE96, A8GXI1, A8H7A5, A8MJX9, A9KGY3, A9N9K2, B0KNE4, B0S2B6, B0TX37, B1GZI5, B1IE21, B1JEP6, B1KDU3, B1KSR1, B2A3J0, B2SFF6, B2UL99, B3CQD1, B4RSV6, B4U955, B5YDB2, B5YIQ7, B6J390
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
58 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 1 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2459 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:41226426:TCTTA:T | donor_loss | 1.0000 |
| 13:41226427:CTTAC:C | donor_loss | 1.0000 |
| 13:41226428:TTA:T | donor_loss | 1.0000 |
| 13:41226429:TACC:T | donor_loss | 1.0000 |
| 13:41226430:A:C | donor_loss | 1.0000 |
| 13:41226431:C:CA | donor_loss | 1.0000 |
| 13:41226431:CCTG:C | donor_gain | 1.0000 |
| 13:41226569:C:CC | acceptor_gain | 1.0000 |
| 13:41233885:CTTA:C | donor_loss | 1.0000 |
| 13:41233886:TTACC:T | donor_loss | 1.0000 |
| 13:41233887:TACC:T | donor_loss | 1.0000 |
| 13:41233888:A:AC | donor_gain | 1.0000 |
| 13:41233889:C:CC | donor_gain | 1.0000 |
| 13:41234006:ACCT:A | acceptor_loss | 1.0000 |
| 13:41234007:CCTA:C | acceptor_loss | 1.0000 |
| 13:41234008:C:CG | acceptor_loss | 1.0000 |
| 13:41234009:T:G | acceptor_loss | 1.0000 |
| 13:41240297:T:A | donor_gain | 1.0000 |
| 13:41252749:TCAC:T | acceptor_gain | 1.0000 |
| 13:41252749:TCACC:T | acceptor_loss | 1.0000 |
| 13:41252750:CAC:C | acceptor_gain | 1.0000 |
| 13:41252750:CACC:C | acceptor_gain | 1.0000 |
| 13:41252751:AC:A | acceptor_gain | 1.0000 |
| 13:41252751:ACC:A | acceptor_loss | 1.0000 |
| 13:41252752:CC:C | acceptor_gain | 1.0000 |
| 13:41252752:CCTAA:C | acceptor_loss | 1.0000 |
| 13:41252753:C:CA | acceptor_loss | 1.0000 |
| 13:41252753:C:CC | acceptor_gain | 1.0000 |
| 13:41252754:T:A | acceptor_loss | 1.0000 |
| 13:41252945:TGA:T | donor_loss | 1.0000 |
AlphaMissense
2945 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:41240355:C:G | R259P | 0.998 |
| 13:41240286:A:T | V282D | 0.997 |
| 13:41240346:C:G | R262P | 0.997 |
| 13:41223296:A:T | V395D | 0.996 |
| 13:41240280:A:T | V284D | 0.996 |
| 13:41240298:C:T | G278E | 0.996 |
| 13:41252733:A:C | F203L | 0.996 |
| 13:41252733:A:T | F203L | 0.996 |
| 13:41252735:A:G | F203L | 0.996 |
| 13:41252742:G:C | C200W | 0.996 |
| 13:41223323:C:G | R386P | 0.995 |
| 13:41233913:A:T | V322D | 0.995 |
| 13:41240305:G:C | H276D | 0.995 |
| 13:41240348:C:A | Q261H | 0.995 |
| 13:41240348:C:G | Q261H | 0.995 |
| 13:41240359:G:C | H258D | 0.995 |
| 13:41240299:C:G | G278R | 0.994 |
| 13:41240299:C:T | G278R | 0.994 |
| 13:41240310:C:G | R274P | 0.994 |
| 13:41240311:G:T | R274S | 0.994 |
| 13:41240352:A:T | V260D | 0.994 |
| 13:41240418:G:T | A238E | 0.994 |
| 13:41223318:A:C | Y388D | 0.993 |
| 13:41233918:A:C | S320R | 0.993 |
| 13:41233918:A:T | S320R | 0.993 |
| 13:41233920:T:G | S320R | 0.993 |
| 13:41240419:C:G | A238P | 0.993 |
| 13:41252743:C:T | C200Y | 0.993 |
| 13:41223283:C:A | R399S | 0.992 |
| 13:41223283:C:G | R399S | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000042901 (13:41247541 C>A), RS1000045505 (13:41284807 C>G,T), RS1000099158 (13:41290652 C>T), RS1000171773 (13:41267994 A>G), RS1000222514 (13:41268352 CTT>C), RS1000265989 (13:41254449 T>C,G), RS1000299452 (13:41310368 G>A), RS1000328771 (13:41297493 A>C,G), RS1000342238 (13:41230287 G>A), RS1000379154 (13:41277498 G>C), RS1000382995 (13:41297214 T>C), RS1000406671 (13:41273440 C>T), RS1000426237 (13:41237285 A>G), RS1000482539 (13:41279177 A>G), RS1000483390 (13:41304189 C>T)
Disease associations
OMIM: gene MIM:604601 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010916_19 | Proportion of activated microglia (inferior temporal cortex) | 7.000000e-06 |
| GCST90013442_21 | Keratoconus | 6.000000e-35 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| monomethylarsonous acid | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | increases expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Mercury | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.